TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Avansor Pharma Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
1,981
|
1,282
|
1,584 |
Financial expenses |
9
|
5
|
1 |
Earnings before taxes |
779
|
421
|
373 |
Total assets |
3,901
|
3,373
|
2,888 |
Current assets |
1,788
|
581
|
822 |
Current liabilities |
551
|
346
|
267 |
Equity capital |
3,050
|
2,728
|
2,621 |
- share capital |
32
![]() |
32
![]() |
32 |
Employees (average) | 3 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
78.2%
|
80.9%
|
90.8% |
Turnover per employee | 528 | ||
Profit as a percentage of turnover |
39.3%
|
32.8%
|
23.5% |
Return on assets (ROA) |
20.2%
|
12.6%
|
13.0% |
Current ratio |
324.5%
|
167.9%
|
307.9% |
Return on equity (ROE) |
25.5%
|
15.4%
|
14.2% |
Change turnover |
699
|
-302 | |
Change turnover % |
55%
|
-19% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.